Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 11—November 2020
Dispatch

Multidrug-Resistant Hypervirulent Group B Streptococcus in Neonatal Invasive Infections, France, 2007–2019

Céline Plainvert, Constantin Hays1, Gérald Touak, Caroline Joubrel-Guyot2, Nicolas Dmytruk, Amandine Frigo, Claire Poyart, and Asmaa TaziComments to Author 
Author affiliations: Assistance Publique–Hôpitaux de Paris Centre Université de Paris, Paris, France (C. Plainvert, C. Hays, C. Joubrel-Guyot, N. Dmytruk, A. Frigo, C. Poyart, A. Tazi); Institut Cochin, Paris (C. Plainvert, G. Touak, C. Poyart, A. Tazi); FHU Prema, Paris (C. Plainvert, C. Poyart, A. Tazi); Université de Paris, Paris (C. Hays, C. Joubrel-Guyot, C. Poyart, A. Tazi)

Main Article

Table 2

Resistance to erythromycin and high-level resistance to amikacin of GBS neonatal isolates, France, 2007–2019*

Year Total GBS isolates, resistance, % (95% CI)
CC17 GBS, resistance, % (95% CI)
Erythromycin Amikacin Erythromycin Amikacin
2007 21.8 (13.0–34.4) 0.0 (0.0–6.5) 17.2 (7.6–34.6) 0.0 (0.0–11.7)
2008 9.0 (4.4–17.4) 1.3 (0.2–6.9) 5.1 (1.4–16.9) 0.0 (0.0–7.7)
2009 19.4 (12.0–30.0) 1.4 (0.3–7.5) 7.1 (2.5–19.0) 0.0 (0.0–9.0)
2010 21.5 (13.9–31.8) 2.5 (0.7–8.8) 16.3 (8.5–29.0) 0.0 (0.0–8.0)
2011 21.7 (13.6–32.8) 1.5 (0.3–7.8) 8.6 (3.0–22.4) 0.0 (0.0–8.8)
2012 10.9 (5.1–21.8) 3.6 (1.0–12.3) 5.3 (1.5–17.3) 2.3 (0.4–11.8)
2013 17.4 (11.6–25.3) 3.5 (1.4–8.6) 10.0 (5.2–18.5) 0.0 (0.0–4.2)
2014 19.1 (12.8–27.4) 11.8 (7.0–19.2) 10.7 (5.5–19.7) 6.5 (3.0–13.5)
2015 25.6 (18.8–33.7) 14.7 (9.6–21.9) 23.4 (15.3–34.0) 10.6 ((5.7–18.9)
2016 18.4 (12.8–25.7) 11.8 (7.4–18.3) 20.8 (13.9–30.0) 8.4 (4.3–15.7)
2017 25.9 (18.7–34.7) 9.8 (5.6–16.7) 20.5 (13.0–30.8) 9.8 (5.0–18.1)
2018 33.1 (25.4–41.7) 16.9 (11.4–24.5) 29.7 (21.3–39.7) 22.4 (14.8–32.3)
2019
29.7 (22.5–38.1)
18.0 (12.3–25.5)

28.6 (20.6–38.2)
14.1 (9.1–21.1)
p for trend† 0.019 <0.0001 0.0042 <0.0001

*CC, clonal complex; GBS, group B Streptococcus.
†Evolutionary trends were analyzed using 2-tailed nonparametric Spearman correlation.

Main Article

1Current affiliation: APHP-Nord (St. Louis) Université de Paris, Paris, France.

2Current affiliation: Le Raincy Hospital, Montfermeil, France.

Page created: August 13, 2020
Page updated: October 19, 2020 12:07 PM EDT
Page reviewed: October 19, 2020 12:07 PM EDT
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external